Barr, R. (2002). “Statement to the Joint FTC/DOJ Hearing on Competition and Intellectual Property Law and Policy in the Knowledge-Based Economy, February 28, 2002.” Available at http://www.ftc.gov/opp/intellect/index.htm.
Bar-Shalom, A. and R. Cook-Deegan. (2002). “Patents and Innovation in Cancer Therapeutics: Lessons from CellPro.” Millbank Quarterly 80(4):637-676.
Barton, J. (2000). “Reforming the Patent System.” Science 287(5460):1933-1934.
Barton, J. (2002). “Antitrust Treatment of Oligopolies with Mutually Blocking Patent Portfolios.” Antitrust Law Journal 69(3):851-882.
Barton, J. (2003). “Non-obviousness.” IDEA: The Journal of Law and Technology 43:475.
Bekkers, R., G. Duysters, and B. Verspagen. (2002) “IPR, strategic technology agreements and market structure: The case of GSM.” Research Policy 31:1141-1161.
Berman, B. (2002). “From Tech Transfer to Joint Ventures – Part 1.” Cafezine. Available at http://www.cafezine.com/index_article.asp?deptId=5&id=555&page=1.
Bernstein, M. (1955). Regulating Business by Independent Commission. Princeton, N.J.: Princeton University Press.
Bessen, J. and E. Maskin. (2000). “Sequential Innovation, Patents and Imitation.” MIT Department of Economics Working Paper Number 00-01. Available at http://papers.ssrn.com/paper.taf?abstract_id=206189.
Blanton, K. (2002). “Corporate Takeover.” Boston Globe (24 Feb. 2002): Magazine.
Branstetter, L., R. Fisman, and C. Foley. (2003). “Do Stronger Intellectual Property Rights Increase International Technology Transfer? Empirical Evidence from U.S. Firm-Level Panel Data.” Unpublished Paper. Available at http://econ.worldbank.org/files/35589_wps3305.pdf.
Burk, D. and M. Lemley. (2003a). “Policy Levers in Patent Law.” Virginia Law Review 89(7):1575-1696.
Burk, D. and M. Lemley. (2003b). “Biotechnology’s Uncertainty Principle.” University of Minnesota School of Law Public Law and Theory Research Paper No. 03-5.
Bush, V. (1945). Science, the Endless Frontier. Washington, D.C.: National Science Foundation.
Chisum, D. (1997). “Best Mode Concealment and Inequitable Conduct In Patent Procurement: A Nutshell, A Review of Recent Federal Circuit Cases and A Plea for Modest Reform.” Santa Clara Computer and High Technology Law Journal 13:277-319.
Cho, M., S. Illangasekare, M. Weaver, D.G.B. Leonard, and J.F. Merz. (2003). “Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services.” Journal of Molecular Diagnostics 5(1):3-8.
Clarke, R. (2003). “U.S. Continuity Law and Its Impact on the Comparative Patenting Rates of the US, Japan, and European Patent Offices.” Journal of the Patent and Trademark Office Society 8(Apr.):335-349.
Cockburn, I. (2004). “The Changing Structure of the Pharmaceutical Industry.” Health Affairs 23(1):10-22.
Cockburn, I., S. Kortum, and S. Stern. (2003). “Are All Patent Examiners Equal? Examiners, Patent Characteristics, and Litigation Outcomes.” In Patents in the Knowledge-Based Economy, W. Cohen and S. Merrill, eds. Washington, D.C.: The National Academies Press.
Cohen, J. and M. Lemley (2001). “Patent Scope and Innovation in the Software Industry.” California Law Review. 89:1-58.
Cohen, W. (2002). “The Pro-Patent Movement in the United States: Indicators and Impacts.” Unpublished Paper.
Cohen, W., A. Goto, A. Nagata, R. Nelson, and J. Walsh. (2002). “R&D Spillovers, Patents and the Incentives to Innovate in Japan and the United States.” Research Policy 31:1349-1367.
Cohen, W., R. Nelson, and J. Walsh. (2000). “Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not).” NBER Working Paper 7552. Available at http://www.nber.org/papers/w7552.